First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...

But it remains to be seen how long this can continue because of dwindling sales of its inflammatory disease drug Remicade and a looming threat to Zytiga. Zytiga (abiraterone), approved since 2011 ...

The charity is urging NICE and Johnson & Johnson (J&J) subsidiary Janssen to return to the negotiating table to try to thrash out an agreement on Zytiga's pricing that would allow the drug to be ...

The cost of prescription drugs in the U.S. isn’t like the tabs for other products. The price for a single medicine can range by thousands of dollars depending on the drug plan. It is a symptom ...

In a live event, Ganesh V. Raj, MD, PhD, discussed the drug-drug interactions and outcomes by disease volumes across ARPI trials in mHSPC.

The large food effect of Zytiga is also avoided ... with only mild-to-moderate side effects reported. Currently, the drug is in Phase II stage of its development for the treatment of prostate ...

In Apotex Inc. v. Janssen Inc., 2022 FC 1473, Janssen markets prostate cancer drug abiraterone acetate in Canada as ZYTIGA, which is listed in the patent register as the 422 Patent. Apotex, Dr.